Literature DB >> 16165319

Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes?

Carl F Marrs1, Lixin Zhang, Betsy Foxman.   

Abstract

A variety of virulence genes are associated with Escherichia coli mediated urinary tract infections. Particular sets of virulence factors shared by bacterial strains directing them through a particular pathogenesis process are called a "pathotype." Comparison of co-occurrence of potential urinary tract infection (UTI) virulence genes among different E. coli isolates from fecal and UTI collections provides evidence for multiple pathotypes of uropathogenic E. coli, but current understanding of critical genetic differences defining the pathotypes is limited. Discovery of additional E. coli genes involved in uropathogenesis and determination of their distribution and co-occurrences will further define UPEC pathotypes and allow for a more detailed analysis of how these pathotypes might differ in how they cause disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16165319     DOI: 10.1016/j.femsle.2005.08.028

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  50 in total

Review 1.  Asymptomatic bacteriuria: when the treatment is worse than the disease.

Authors:  Barbara W Trautner
Journal:  Nat Rev Urol       Date:  2011-12-06       Impact factor: 14.432

2.  Identification of Escherichia coli genes associated with urinary tract infections.

Authors:  Bin-Hsu Mao; Yung-Fu Chang; Joy Scaria; Chih-Ching Chang; Li-Wei Chou; Ni Tien; Jiunn-Jong Wu; Chin-Chung Tseng; Ming-Cheng Wang; Chao-Chin Chang; Yuan-Man Hsu; Ching-Hao Teng
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

3.  Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains.

Authors:  Concetta Restieri; Geneviève Garriss; Marie-Claude Locas; Charles M Dozois
Journal:  Appl Environ Microbiol       Date:  2007-01-12       Impact factor: 4.792

4.  The role of Escherichia coli in inflammatory bowel disease.

Authors:  Jonathan M Rhodes
Journal:  Gut       Date:  2007-05       Impact factor: 23.059

5.  Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins.

Authors:  Travis J Wiles; Bijaya K Dhakal; Danelle S Eto; Matthew A Mulvey
Journal:  Mol Biol Cell       Date:  2008-01-30       Impact factor: 4.138

Review 6.  Rapid Growth and Metabolism of Uropathogenic Escherichia coli in Relation to Urine Composition.

Authors:  Larry Reitzer; Philippe Zimmern
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

7.  Chinese herb-resistance and adherence to human uroepithelial cells of uropathogenic Escherichia coli.

Authors:  YanQing Tong; Bing Xin; Ying Chi
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-11-02

Review 8.  A Thermosensitive, Phase-Variable Epigenetic Switch: pap Revisited.

Authors:  Mario Zamora; Christine A Ziegler; Peter L Freddolino; Alan J Wolfe
Journal:  Microbiol Mol Biol Rev       Date:  2020-07-29       Impact factor: 11.056

9.  Insulin and the phosphatidylinositol 3-kinase signaling pathway regulate Ribonuclease 7 expression in the human urinary tract.

Authors:  Tad E Eichler; Brian Becknell; Robert S Easterling; Susan E Ingraham; Daniel M Cohen; Andrew L Schwaderer; David S Hains; Birong Li; Ariel Cohen; Jackie Metheny; Susheela Tridandapani; John David Spencer
Journal:  Kidney Int       Date:  2016-07-09       Impact factor: 10.612

10.  Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli.

Authors:  Travis J Wiles; Jean M Bower; Michael J Redd; Matthew A Mulvey
Journal:  PLoS Pathog       Date:  2009-12-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.